According to the National Diabetes Education Program, “National Diabetes Month is observed every November to draw attention to diabetes and its effects on millions of Americans.” The NDEP’s 2015 theme, Diabetes Education and Support: Everyone Has a Role. What’s Yours?, “highlights the need for ongoing diabetes education and support among people with diabetes and those who care for them.”
Obesity is a major risk factor for the development of type 2 diabetes; therefore, prevention and treatment of obesity is of utmost importance to help control or minimize the effects of type 2 diabetes. Studies show that metabolic control of diabetes can reduce the associated complications.
According to a medical protocol written by Robard Medical Advisory Panel member Christopher Case, MD, “Recent research has elucidated the pathophysiology of diabetes, suggesting that insulin resistance and beta-cell dysfunction as key components. Weight loss can address the underlying pathophysiology of type 2 diabetes, even within one week on a Very Low Calorie Diet (VLCD). Diet-induced weight loss through a VLCD removes stores of ectopic fat outside the fat cell, improving beta-cell function, as well as blood pressure and cholesterol. This is often associated with a reduction in medications to treat type 2 diabetes and an improved quality of life.
Robard offers a suite of materials related to type 2 diabetes for you and your patients. In addition to our extensive Diabetes Medical Protocol, we offer patient education modules, patient brochures, and more, to assist you with explaining the correlation between type 2 diabetes and obesity. Our medical protocols are also available on our website. To view the protocols, login to www.Robard.com
, and visit “Medical Protocols” under the “Education” tab in the top navigation. By using Robard’s frequently asked questions and patient handout on type 2 diabetes, you can further educate your patients on recommendations for suggested initial testing, ongoing monitoring, and contraindications/risks.
Read More >>
7. October 2015
Diabetes , Obesity
Your cash register receipts are making you fat. OK, that may not be exactly the case — but a chemical used in those receipts as well as many other common items has been found to have a link to obesity and diabetes. The chemical is called endocrine-disrupting chemicals (EDCs), and it’s everywhere.
According to the executive summary of a Scientific Statement issued by the Endocrine Society, “Known EDCs include bisphenol A (BPA) found in food can linings and cash register receipts, phthalates found in plastics and cosmetics, flame retardants and pesticides. The chemicals are so common that nearly every person on Earth has been exposed to one or more.” It’s believed that EDC exposure has cost the European Union 209 billion dollars a year in health care expenses and earning potential.
The threat from these chemicals is that they block or interfere with the body’s natural hormones and create an adverse effect on cell development as a result. Exposure can lead to obesity, diabetes, infertility, hormone-related cancers, neurological issues and other disorders.
“The evidence is more definitive than ever before,” says Andrea C. Gore, Professor and Vacek Chair of Pharmacology at the University of Texas at Austin and chair of the task force that developed the statement. “EDCs disrupt hormones in a manner that harms human health.”
The Endocrine Society researchers consider the situation dire and have come up with a plan to combat it. The plan consists of initiatives suggesting further research about potential exposure effects, regulation on the use of the chemicals, and calling upon “green chemists” to provide possible alternatives or solutions to stop EDC usage, among other things.
A recent study showed that people today are eating and exercising the same amount as people 20 years ago (we’ll feature that in an upcoming blog), but the United States is collectively more overweight than ever. One of the reasons could include toxins that we are exposed to — and research such as this adds validity to such claims.
Source: The Endocrine Society
Read More >>
, a leading developer and provider of obesity treatment programs and products, announced today that it has acquired DiabetesCare.net
, an online educational source for diabetes related news, interviews, blogs, and free-to-use tools. With this acquisition, Robard aims to further diversify the information and resources it offers to healthcare professionals in the field of obesity treatment while augmenting the online presence and value of www.Robard.com
“Diabetes is a worldwide epidemic that causes significant morbidity and mortality, and obesity is a major risk factor for the development of type 2 diabetes,” said Robert Schwartz, President, Robard Corporation. “The prevention and treatment of obesity is of utmost importance to help control or minimize the effects of type 2 diabetes. The comprehensive obesity treatment programs, services and protocols offered by Robard are significantly enriched by the educational components of DiabetesCare.net.”
About Robard Corporation
For 40 years, Robard Corporation’s comprehensive medical and non-medical obesity treatment programs and state of the art nutrition products have enabled a vast network of physicians, large medical groups, hospital systems and clinics to maximize profit, grow their business and successfully treat thousands of overweight and obese patients. For more information, please visit www.Robard.com
Read More >>